Skip to main content

Economical evaluation of vaccine programs

Guest Editors:
Sayem Ahmed: School of Health and Wellbeing, University of Glasgow, UK
Saskia den Boon: World Health Organization, Switzerland
Edris Hasanpoor: Maragheh University of Medical Sciences, Iran
Abdur Razzaque Sarker: Bangladesh Institute of Development Studies, Bangladesh



BMC Health Services Research accepted submissions focusing on Economic evaluations of vaccination programs. Immunization is considered a key component of primary healthcare and has become essential not only for the prevention and control of infectious disease outbreaks but also for reducing the use of infectious diseases-associated healthcare resources. Defined as governmental programs aimed at achieving optimal vaccination coverage in the general population or in susceptible subgroups, vaccination or immunization programs include purchase, storage, distribution, recommendations and campaigns related to a certain vaccine. The scale of global and national vaccination programs continues to grow along with the notion that vaccines represent amongst the most cost-effective healthcare measures, resulting in a proportional increase in government vaccines expenditure.

Meet the Guest Editors

Back to top

Sayem Ahmed: School of Health and Wellbeing, University of Glasgow, UK

Dr Ahmed is a Research Associate at the Health Economics and Health Technology Assessment (HEHTA) research group, University of Glasgow. His research deals with estimating health economic burden and economic evaluation of interventions targeting infectious diseases especially neglected tropical and vaccine-preventable ones. In addition, Sayem conducted research on health insurance, healthcare financing, financial risk protection for universal health coverage and health systems efficiency in low and middle-income countries. He is currently working on several research studies at HEHTA undertaking economic evaluations alongside clinical trials.

Saskia den Boon: World Health Organization, Switzerland

Saskia den Boon is a technical officer in the Global Tuberculosis Programme of WHO, where she works on TB screening and prevention as well as research and innovation. She previously worked as a consultant for the WHO Department of Immunizations, Vaccines and Biologicals where she was involved in economical evaluations of vaccine programs. Saskia holds a MSc in Health Economics, Policy and Management from LSE, and a PhD in tuberculosis epidemiology from the University of Amsterdam.

Edris Hasanpoor: Maragheh University of Medical Sciences, Iran

Edris Hasanpoor got his Ph.D., in Healthcare Management, Fellowship of Evidence-Based Medicine from Joanna Briggs Institute (JBI) affiliated to Adelaide University of Australia. He is an Assistant Professor at Maragheh University of Medical Sciences.  He is responsible for the establishment of the Research Center for Evidence-Based Health Management in Maragheh. Dr. Hasanpoor's research focuses on three important problems in healthcare: non-evidence based decisions in healthcare, overuse in medical care and poor medical communication.

Abdur Razzaque Sarker: Bangladesh Institute of Development Studies, Bangladesh

Dr Abdur Razzaque Sarker is a Health Economist working at the Bangladesh Institute of Development Studies (BIDS). He is a trained researcher and has worked in health systems and economic analysis in developed and developing nations. Earlier, he worked as a Health Economist Researcher at the University of Birmingham, Mahidol Oxford Tropical Medicine Research Unit, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b). Dr Sarker AR obtained his Ph.D. from the University of Strathclyde, United Kingdom, and completed his 'Master of Health Economics' and 'Master of Economics' from Bangladesh. His research focuses on health economics issues, particularly economic analysis from various perspectives, economic evaluation of public health programs, including the economics of vaccine-preventable diseases, the economics of non-communicable diseases, quality of life research, and healthcare financing issues and immunization economics.

About the collection

BMC Health Services Research is now accepting submissions focusing on Economic evaluations of vaccination programs. Immunization is considered a key component of primary healthcare and has become essential not only for the prevention and control of infectious disease outbreaks but also for reducing the use of infectious diseases-associated healthcare resources. Defined as governmental programs aimed at achieving optimal vaccination coverage in the general population or in susceptible subgroups, vaccination or immunization programs include purchase, storage, distribution, recommendations and campaigns related to a certain vaccine. The scale of global and national vaccination programs continues to grow along with the notion that vaccines represent amongst the most cost-effective healthcare measures, resulting in a proportional increase in government vaccines expenditure.
The quantitative analysis of the costs associated with immunization programs, together with the evaluation of their effectiveness in achieving its healthcare goals, thus becomes a key tool to guide health policy makers and public health financing decisions.

This collection welcomes articles on:
•    Economic evaluations of vaccination programs and their methodological approaches and predictive models.
•    Analysis of the costs of vaccine delivery programs.
•    Cost-effectiveness and cost-utility analysis of vaccination programs.
•    Incorporation of health economic evaluations for vaccination policy making and for immunization planning.
•    Guidelines for economic evaluations of vaccines and immunization programs.
 

Image credit: © J J / stock.adobe.com

  1. Africa has some of the highest cervical cancer incidence and mortality rates globally. Burkina Faso launched a human papillomavirus (HPV) vaccination programme for 9-year-old girls in 2022 with support from Ga...

    Authors: Joël Arthur Kiendrébéogo, Annick Raissa O. Sidibe, Ghislain Bertrand Compaoré, Relwendé Nacanabo, Orokia Sory, Issa Ouédraogo, Saira Nawaz, Anne E Schuind and Andrew Clark
    Citation: BMC Health Services Research 2023 23:1338
    Content type: Research Published on:

  3. Argentina currently uses a pentavalent vaccine containing diphtheria, tetanus, pertussis (whole cell), Haemophilus influenza type b and hepatitis B antigens, administered concomitantly with the inactivated polio ...

    Authors: Ignacio Olivera, Carlos Grau Pérez, Luis Lazarov, Eduardo Lopez, Cristian Oddo and Hugo Dibarboure
    Citation: BMC Health Services Research 2023 23:1067
    Content type: Research Published on:

Submission Guidelines

Back to top

This Collection welcomes submission of Research Articles. Before submitting your manuscript, please ensure you have read our submission guidelines. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select ["Economical Evaluation of Vaccine Programs"] from the dropdown menu.

Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.

The Guest Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Guest Editors have competing interests is handled by another Editorial Board Member who has no competing interests.